This article is more than 5 years old. Information may no longer be current.

VIDEO: Speaker — Early anti-VEGF treatment yields better final outcomes in CNV

Issue: January 2016

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

FLORENCE, Italy — At the FLOREtina meeting, Young-Hee Yoon, MD, PhD, gives her views on when to start and how long to continue anti-VEGF treatment for myopic choroidal neovascularization. Based on 5-year follow-up data, Yoon addresses questions that were not resolved in pivotal trials.